Pionyr Immunotherapeutics Stock

www.pionyrtx.comHealthcare / BioTech & PharmaFounded: 2015

Pionyr Immunotherapeutics develops cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity and ability to combat cancer.

Register for Details

For more details on financing and valuation for Pionyr Immunotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Pionyr Immunotherapeutics.

Register Today

Other companies like Pionyr Immunotherapeutics in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B